§ PHARMACEUTICALS
USD · Pharmaceuticals

AQST

AQUESTIVE THERAPEUTICS INC
USDSector · PharmaceuticalsBeta · 1.47
LAST
n/a
n/aPREV CLOSE · n/a
§ 01 · PRICE
Price action
1D5D1M6MYTD1YMAX

§ 03 · SIGNAL STACK · WHAT THE INPUTS SAY

13F FLOW
105 increased/new, 46 decreased/exited (13F)
AC 13F Analysis

§ 04 · FUNDAMENTALS · THE BOOKS

P/B15.59EPS (TTM)-0.60
§ 05 · WHO OWNS IT
Top institutional holders
All holders →
FundShares% portΔ Q/Q
Bratton Capital Management, L.P.9.8M100.0%±0%
BlackRock, Inc.7.5M0.0%−3%
RTW INVESTMENTS, LP7.4M0.3%+19%
VANGUARD CAPITAL MANAGEMENT LLC4.4Mn/an/a
FEDERATED HERMES, INC.2.9M0.0%+45%
Balyasny Asset Management2.9M0.0%+199%
◇ AC INTELLIGENCE

Top institutional owners for AQST as of the most recent 13F reporting period (Q1 2026 · Period ended Mar 31). Δ Q/Q reflects share-count change vs. the prior filing — positive green means adding, negative red means trimming. Cross-reference with the ownership-mix bars below to see which strategy cohort is driving the flow.

§ 06 · WHO OWNS IT · BY STRATEGY

OTHER83.7% · 0 holders
OTHER9.5% · 129 holders
DEALER / BANK2.5% · 20 holders
PASSIVE / INDEX2.3% · 8 holders
TACTICAL / MACRO0.9% · 4 holders
QUALITY / COMPOUNDER0.8% · 8 holders
SYSTEMATIC / QUANT0.3% · 7 holders
INCOME / DEFENSIVE0.1% · 7 holders
ACTIVIST0.0% · 1 holder
GROWTH / MOMENTUM0.0% · 1 holder
◇ AC INTELLIGENCE

Ownership mix by behavioral cohort. Top bars indicate which style of capital dominates the float — passive indexing, quality compounders, dealer/bank, systematic quant, etc. Big quality-compounder share means concentrated active conviction; heavy passive share means flows are dictated by index rebalances, not fundamentals.

§ 07 · INSIDER ACTIVITY · LAST 180 DAYS

NO INSIDER FILINGS
◇ AC INTELLIGENCE

No Form 4 filings on record for AQST in the last 180 days.

§ 08 · COVERAGE · OUR RECENT NOTES

No notes mention AQST yet.